ADPT

What Does an Adaptive Biotech Insider's Sale of Nearly 40,000 Shares Mean for Investors?

06/14 06:26 pm

Harvest Investment Services Dumps 356,000 Adaptive Biotechnologies (ADPT) Shares Worth $5.7 Million

05/26 04:03 pm

Adaptive Biotechnologies' Chief Operating Officer Sold Over 19,000 Company Shares. Here's What That Means for Investors.

05/04 05:29 pm

Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares?

04/18 10:37 am

Adaptive Biotech Insider Sells $554K as Revenue Jumps 55%, but Here's What Investors Should Focus On

04/08 09:13 am

Adaptive Biotech's President Trimmed Her Position. But what Remains is worth a look

03/30 08:08 pm

Adaptive Biotech Insider Sale of 180,000 Shares Tied to Tax Event as Stock Jumps 70% in a Year

03/26 12:13 pm

Pfizer Faces Another Quiet Year As Patent Losses Cloud 2026 Outlook: Analyst

12/15 01:31 pm

Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting

12/06 09:30 am

Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal?

12/05 02:33 pm

Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday

08/06 07:01 pm

U.S. Minimal Residual Disease Testing Market Trends Analysis Report 2025-2033 | Integration with Personalized Medicines, & Rising Incidence and Prevalence of Hematological Malignancies Fueling Growth

07/25 04:59 am

Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers

05/30 07:30 am

Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide

04/08 04:48 am

Cutting-Edge Cancer Therapies Lead the Way into a Transformative Year

01/15 11:10 am

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions

12/07 07:30 pm

Laboratory-Developed Tests (LDTs) World Market Forecast Report to 2028, with Coverage of the Effects of the FDA's New "Medical Devices: Laboratory Developed Tests" Rule, Passed in April 2024

08/15 10:58 am

Hematologic Malignancies Testing Markets, 2023-2033: Growing Utilization of Next-Generation Sequencing and AI, Increasing Partnerships, Alliances, and Business Expansions among Key Players

08/13 04:58 am

Agenus (AGEN) Tanks on Colorectal Cancer Study Interim Data - Zacks Investment Research

07/19 10:00 am

Arcutis (ARQT) Stock Rises 31% in the Past Month: Here's Why - Zacks Investment Research

07/17 10:01 am

Lisata (LSTA) Stock Rallies More Than 30% YTD: Here's Why - Zacks Investment Research

07/16 10:30 am

Athira (ATHA) Completes Dosing in Alzheimer's Study, Stock Up - Zacks Investment Research

07/10 09:01 am

Cathie Wood-Led Ark Invest Scoops Up $5.16M Worth Of Palantir Shares Amid Raging AI Fervor

07/01 10:19 pm

Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

05/31 07:30 am

Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

05/29 04:05 pm

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

05/22 11:15 am

Why Adaptive Biotechnologies Topped the Market Today

05/08 06:43 pm

Compared to Estimates, Adaptive Biotechnologies (ADPT) Q1 Earnings: A Look at Key Metrics

05/07 07:30 pm

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Misses Revenue Estimates

05/07 05:40 pm

Adaptive Biotechnologies Reports First Quarter 2024 Financial Results

05/07 04:05 pm

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

04/17 01:36 pm

Adaptive Biotechnologies Names New CFO Preserves Strong Capital Position

04/03 01:42 pm

Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue

04/02 04:05 pm

Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference

02/22 05:05 pm

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results

02/14 05:05 pm

Exploring Analyst Estimates for Adaptive Biotechnologies (ADPT) Q4 Earnings, Beyond Revenue and EPS

02/12 10:16 am

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024

01/29 05:05 pm

Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference

12/27 05:05 pm

Cathie Wood's Ark Invest Sells Nearly $11.5M Worth Of Coinbase Shares As Bitcoin, Crypto Rally Loses Steam

12/13 12:22 am

Cathie Wood Is Loading Up on These 3 Small-Cap Stocks: Should You?

12/12 06:50 am

Cathie Wood's Ark Dumps $12.8M Worth Of Grayscale Bitcoin Trust Amid Crypto Rally Losing Wind In Sails

12/11 11:55 pm

Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting

12/09 09:30 am

Cathie Wood's Ark Invest Trims Bitcoin Exposure, Sells $2.9M Worth Of GBTC Shares Amid Crypto Market Volatility

12/07 11:10 pm

Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting

12/05 08:30 am

Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

11/14 03:05 pm

Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday

11/14 11:39 am

Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session

11/10 02:34 pm

Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ® Assay Across BeiGene’s Lymphoid Malignancy Pipeline

11/07 08:30 am

Adaptive Biotechnologies (ADPT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

10/26 10:02 am

Expert Ratings for Adaptive Biotechnologies

10/24 11:00 am